The targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapy

Docosahexaenoic acid (DHA), an omega-3 C22 natural fatty acid serving as a precursor for metabolic and biochemical pathways, was reported as a targeting ligand of anticancer drugs. However, its tumor targeting ability and mechanism has not been claimed. Here we hypothesized that the uptake of DHA by...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Li, Siwen, Qin, Jingyi, Tian, Caiping, Cao, Jie, Fida, Guissi, Wang, Zhaohui, Chen, Haiyan, Qian, Zhiyu, Chen, Wei R, Gu, Yueqing
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2014
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4116508/
https://ncbi.nlm.nih.gov/pubmed/25004114
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items